Page last updated: 2024-10-31

mianserin and Movement Disorders

mianserin has been researched along with Movement Disorders in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sparring Björkstén, K1
Wålinder, J1

Other Studies

1 other study available for mianserin and Movement Disorders

ArticleYear
Does mianserin induce involuntary movements in brain damaged patients?
    International clinical psychopharmacology, 1993,Fall, Volume: 8, Issue:3

    Topics: Aged; Brain Damage, Chronic; Dyskinesia, Drug-Induced; Female; Humans; Mianserin; Movement Disorders

1993